Medpace Holdings IncMEDP
ASignal's systematic analysis rates MEDP as Bullish.
Reflects the latest available analysis · analyzed Aug 30, 2026
The case on MEDP
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (17.2% YoY)
- High gross margin (72.35%) indicating pricing power
- Exceptional return on equity (162.15%)
- Positive free cash flow ($510.4M)
- Low debt-to-equity ratio (0.33x)
- Forward P/E below current P/E (31.11x vs 35.84x)
- MACD below signal line indicating bearish momentum
- Negative MACD histogram suggesting weakening trend
- Current ratio (0.73x) and quick ratio (0.66x) below 1, indicating liquidity concerns
- PEG ratio elevated at 3.27x, suggesting overvaluation relative to growth
See the full verdict on MEDP
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MEDP
Most investors never get a second opinion, let alone several. ASignal runs MEDP past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.